Back to Dashboard
44

PNTG

🏥 Healthcare

The Pennant Group, Inc.

Conservative #760Aggressive #187Moderate RiskML↑ 23pt
$30.49-7.86%
Day High$31.89
Day Low$28.79
Volume0.7M
Mkt Cap$1.1B
52W Low $2152W High $33
Market Cap
$1.1B
P/E Ratio
41.9
Sector avg: 41.9
Rev Growth
27.6%
Sector avg: 161.5%
Earnings Growth
68.6%
Profit Margin
3.2%
Sector avg: -3292.7%
Debt/Equity
0.94

Why This Score

PNTG scores 45.2 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.

Risk Factors
  • Liquidity concern: Limited trading volume or float results in a 5-point penalty for execution risk.
  • Elevated valuation at 41.9x earnings — requires sustained growth to justify the premium.
  • Above-average volatility (10.4%) may not suit conservative risk tolerance.

Moderate penalties (-5.0 points) reflect identified risk factors. The overall score balances these against the stock's fundamental strengths.

Score Breakdown

Overall Score45.2
Fundamental Score44.7
ML Score52.0

Score by Horizon

3 Month
70.5
6 Month
78.8
Primary
1 Year
82.9

Quality Assessment

D
Quality Grade
Below average quality — weak profitability or high leverage

Position Sizing

Suggested Allocation
5%
Confidence
high

Score Composition Waterfall

How each component affects the final score
Backtested Scoring Levers (IC-calibrated from 30y ElasticNet)
Weinstein (12.1%)
100
Advancing
Sentiment (2.5%)
70
Positive
Analyst (6.4%)
71
Favorable
Tradability (post-hoc)
59
Grade C
Base
41.2
SHAP
+2.8
Factors
+1.2
Final
45.2
Positive adjustment
Negative adjustment
Base blend
Final score

Factor Breakdown

63AVG
Value48
Quality34
Growth98
Stability69
Investment65

Signal SegmentsComputed from ML features

Fundamental (Valuation, Quality, Growth)54.0
Technical (Momentum, Weinstein, Volatility)80.0
External (Sentiment, Analyst, Macro)85.0
Scores below 50 indicate weakness in that segment relative to the universe.

Data Quality

Score
Features
Confidence
Feature Coverage89%

Growth Estimates

Short-term
+4.7% to +9.8%
Medium-term
+8.0% to +15.8%
Long-term
+11.9% to +22.4%

ML Model Core Features100 trained inputs → ML Score: 52

These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.

Analyst Intelligence
Consensus Score71.4/100
Target Upside+19.9%
Coverage7 analysts
Market Sentiment
Sentiment Score69.9/100
News Volume1 articles
Technical Stage
Weinstein Stage2 — Advancing
12M Momentum+0.4%
6M Momentum+0.3%
Volatility+0.1%
Momentum & Technical
Momentum Acceleration+7.3%
Momentum ConsistencyStrong (0.82)
Relative Strength vs Sector+16.0%
Trend Strength (ADX Proxy)Strong (3.9)
Momentum Quality+0.300
Momentum BreadthBroad ✓
Macro Regime
Bull RegimeYes
High Vol RegimeNo
S&P 500 Return+25.0%
Yield Curve-0.1bp

Sector-Relative AnalysisIn-model features

Value Trap Signal
2%
Low risk
Sector RevGr Rank
P76
Revenue growth vs Healthcare peers
Sector PE Rank
P10
Valuation vs Healthcare peers
Sector FCF Rank
P73
Free cash flow vs Healthcare peers
Growth Deviation
+0.0σ
Z-score vs sector median
Stagnation Flag
NO
Not flagged

Analysis Signals

Scoring Factors
Fundamental score of 45 relative to sector peers45/100
Machine learning ensemble ranks this stock at the 52th percentileP52
Blended score: 80% fundamental (45) + 20% ML (52) = 46.246.2
Risk assessment: low. Low vol 0.1%; Drawdown 26% → 0.0ptLow
Earnings quality grade D: weak earnings quality, multiple concerns. Score adjusted by 0 pointsGrade D
SHAP feature alignment: +2.8pt (features align with model priorities)SHAP
Risk Factors
Liquidity penalty: -5.0pt (grade C)Liquidity

Sector Peer Comparison(Healthcare — Rank #110 of 344 stocks)

StockScoreP/ERev GrowthMarginMkt Cap
PNTG45.241.927.6%3.2%$1.1B
INCY89.915.821.2%25.0%$19.6B
GMAB86.113.122.8%36.4%$17.9B
CPRX83.713.723.5%37.6%$3.0B
ASND78.316.698.0%-31.7%$13.8B
EXEL78.315.17.0%33.7%$11.9B
VRTX78.232.18.9%32.9%$121.8B
NBIX75.126.521.4%16.7%$13.1B
RPRX75.025.15.1%32.4%$19.3B
HOLX74.831.11.7%13.8%$16.8B
AMGN74.226.010.0%21.0%$204.8B
ARGX73.735.178.6%38.0%$47.4B
REGN73.019.41.0%31.4%$80.2B
ALKS72.916.5-6.4%23.9%$5.0B
ISRG72.761.720.5%28.4%$180.9B
KRYS71.541.4473.0%30.7%$7.9B
Sector Average36.641.9161.5%-3292.7%—

Company Overviewvia FMP

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

CEO
Brent J. Guerisoli
Employees
7,000
Beta
1.28
Industry
Medical - Care Facilities
FMP-Identified Peers

Technical Picturecomputed from daily prices

RSI (14)
52.9
Neutral
Trend
Bullish
10-day vs 50-day MA
From 52W High
-8.5%
High: $33.31
From 52W Low
+44%
Low: $21.18
Moving Averages
10-Day
$32.00
Below
20-Day
$30.80
Below
50-Day
$29.80
Above
200-Day
$26.90
Above
60-Day Support
$26.67
60-Day Resistance
$33.31
Weinstein Stage Analysisbased on 200-day SMA framework
Stage 2 — AdvancingScore: 72/100

Stock is in an uptrend above the 200-day moving average. This is the stage where institutional accumulation typically occurs. The 50-day SMA provides support.

Favorable technical position; 50-day SMA acts as support
Price vs 200 SMA
+13.3%
200 SMA Slope (60d)
+5.42%
Rising
Volume Ratio
1.09x
10d avg vs 50d avg
Days in Stage
68
Confidence: 90%

Financial Statementslast 4 quarters via FMP

MetricQ4 2025Q3 2025Q2 2025Q1 2025
Revenue$289M$229M$220M$210M
Gross Profit$0$46M$30M$29M
Operating Income$17M$10M$12M$13M
Net Income$9M$6M$7M$8M
EPS (Diluted)$0.24$0.17$0.20$0.22
Gross Margin0.0%20.2%13.8%14.0%
Operating Margin6.0%4.5%5.3%6.0%
Net Margin3.0%2.7%3.2%3.7%

Why This Stock

HealthcareRevenue growth 27.6%

Tradability FilterGrade C — 59/100Score impact: -19.9pt

Volume
57
265K avg/day
Dollar Vol
57
$9M/day
Float
63
33M shares
Mkt Cap
43
$1.1B
Range
88
56% spread
Composite Liquidity Score59/100
FDCBA

Multi-Year Range Analysis

Sideways: 0/100
YearLowHighRangeStatus
2021$17.52$59.17108.6%Wide
2022$8.68$24.2394.5%Wide
2023$10.00$16.3948.4%Wide
2024$13.77$37.1391.8%Wide
2025$21.18$30.4635.9%Wide
3-Year Range
115.1%
Narrow Years
0 / 5
Sideways Penalty
None
Free Float
95.2%
Outstanding Shares
35M
Bid-Ask Spread
56.0%
Institutional Tradable
Limited

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.